You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 4, April 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 67TH ANNUAL MEETING OF THE NEW ENGLAND SURGICAL SOCIETY, DIXVILLE NOTCH, NH, SEPTEMBER 26-28, 1986
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Electrocoagulation for Intraoral Cancer

Charles S. Whelan, MD, DSc (Hon); David E. Marcello, Jr, DMD, MD; W. Bradford Patterson, MD; Peter J. Deckers, MD

Arch Surg. 1987;122(4):484-487.


Abstract

• Electrocoagulation of 58 intraoral lesions (1 to 6.5 cm in diameter) resulted in a three-year absolute disease-free survival rate of 59% (34/58). During the 20-year study, 43 (74%) of the 58 patients were cured. Though an initial 28% local failure rate was observed, 31% (5/16) of these patients were subsequently cured by a second electrocoagulation. Electrocoagulation has distinct advantages over conventional surgery and irradiation. Relatively little tissue beyond the tumor is coagulated. Such tissue sparing allows better postoperative function and cosmesis. The deleterious effects of irradiation, including the serious "dry-mouth" syndrome, are avoided. These treatment results are competitive with those of conventional surgery and irradiation. The limited field treated, the tissue conservation, the minimal morbidity, and the cost-effectiveness should make electrocoagulation a real consideration in treating selected invasive intraoral tumors. Ideally suited for electrocoagulation are those patients whose lesions are small, easily visualized, mobile, and well differentiated.

(Arch Surg 1987;122:484-487)



Author Affiliations

From the Departments of Surgery, University of Massachusetts Medical School, Worcester (Dr Whelan); Boston University School of Medicine (Drs Whelan and Marcello); Brockton (Mass) Hospital (Dr Marcello); Harvard Medical School, Boston (Dr Patterson); University of Connecticut School of Medicine, Farmington (Dr Deckers); and Hartford (Conn) Hospital (Dr Deckers); and the Division of Cancer Control, Dana-Farber Cancer Institute, Boston (Dr Patterson).


Footnotes

Accepted for publication Jan 5, 1987.

Read before the 67th Annual Meeting of the New England Surgical Society, Dixville Notch, NH, Sept 28, 1986.

Reprint requests to 29 Valley View Dr, Avon, CT 06001 (Dr Whelan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.